ENDRA LIFE SCIENCES INC.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $233.7K | — | $776.4K | — | — | $432.1K | — |
| SG&A Expense | — | $1.2M | — | $1.4M | — | — | $893.3K | — |
| Operating Income | — | $-1.5M | — | $-2.2M | — | — | $-1.4M | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $159.9K | — | $-1.3M | — | — | $-1.6M | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $159.9K | — | $-1.3M | — | — | $-1.6M | — |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | $0.12 | — | $-1.09 | — | — | $-0.53 | — |
| EPS (Diluted) | — | $0.06 | — | $-1.09 | — | — | $-0.53 | — |
| Shares Outstanding (Basic) | 1.5M | 1.3M | 1.3M | 1.2M | 1.2M | 4.7M | 3.0M | 3.0M |
| Shares Outstanding (Diluted) | 1.5M | 2.5M | 1.3M | 1.2M | 1.2M | 4.7M | 3.0M | 3.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |